Literature DB >> 25189459

A primer on marginal effects--Part I: Theory and formulae.

Eberechukwu Onukwugha1, Jason Bergtold, Rahul Jain.   

Abstract

Marginal analysis evaluates changes in an objective function associated with a unit change in a relevant variable. The primary statistic of marginal analysis is the marginal effect (ME). The ME facilitates the examination of outcomes for defined patient profiles while measuring the change in original units (e.g., costs, probabilities). The ME has a long history in economics; however, it is not widely used in health services research despite its flexibility and ability to provide unique insights. This paper, the first in a two-part series, introduces and illustrates the calculation of the ME for a variety of regression models often used in health services research. Part One includes a review of prior studies discussing MEs, followed by derivation of ME formulas for various regression models including linear, logistic, multinomial logit model (MLM), generalized linear model (GLM) for continuous data, GLM for count data, two-part model, sample selection (two-stage) model, and parametric survival model. Prior theoretical papers in health services research reported the derivation and interpretation of ME primarily for the linear and logistic models, with less emphasis on count models, survival models, MLM, two-part models, and sample selection models. These additional models are relevant for health services research studies examining costs and utilization. Part Two of the series will focus on the methods for estimating and interpreting the ME in applied research. The illustration, discussion, and application of ME in this two-part series support the conduct of future studies applying the marginal concept.

Entities:  

Mesh:

Year:  2015        PMID: 25189459     DOI: 10.1007/s40273-014-0210-6

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  5 in total

1.  The logged dependent variable, heteroscedasticity, and the retransformation problem.

Authors:  W G Manning
Journal:  J Health Econ       Date:  1998-06       Impact factor: 3.883

Review 2.  Overview of parametric survival analysis for health-economic applications.

Authors:  K Jack Ishak; Noemi Kreif; Agnes Benedict; Noemi Muszbek
Journal:  Pharmacoeconomics       Date:  2013-08       Impact factor: 4.981

3.  Computation of standard errors.

Authors:  Bryan E Dowd; William H Greene; Edward C Norton
Journal:  Health Serv Res       Date:  2014-04       Impact factor: 3.402

Review 4.  Explaining marginal benefits to patients, when "marginal" means additional but not necessarily small.

Authors:  Thomas J Smith; Bruce E Hillner
Journal:  Clin Cancer Res       Date:  2010-12-15       Impact factor: 12.531

5.  Interaction terms in nonlinear models.

Authors:  Pinar Karaca-Mandic; Edward C Norton; Bryan Dowd
Journal:  Health Serv Res       Date:  2011-08-30       Impact factor: 3.734

  5 in total
  6 in total

1.  Cost Savings of Mother's Own Milk for Very Low Birth Weight Infants in the Neonatal Intensive Care Unit.

Authors:  Tricia J Johnson; Aloka L Patel; Michael E Schoeny; Paula P Meier
Journal:  Pharmacoecon Open       Date:  2022-02-11

2.  Prevalence of HIV at the Kokoyo informal gold mining site: what lies behind the glitter of gold with regard to HIV epidemics in Mali? A community-based approach (the ANRS-12339 Sanu Gundo cross-sectional survey).

Authors:  Luis Sagaon-Teyssier; Hubert Balique; Fodié Diallo; Nikos Kalampalikis; Marion Mora; Michel Bourrelly; Marie Suzan-Monti; Bruno Spire; Bintou Dembélé Keita
Journal:  BMJ Open       Date:  2017-08-03       Impact factor: 2.692

3.  Impact of Per Capita Income on the Effectiveness of School-Based Health Education Programs to Promote Cervical Cancer Screening Uptake in Southern Mozambique.

Authors:  Floriano Amimo; Troy D Moon; Anthony Magit; Jahit Sacarlal
Journal:  J Glob Infect Dis       Date:  2018 Jul-Sep

4.  Providing dental insurance can positively impact oral health outcomes in Ontario.

Authors:  Nevena Zivkovic; Musfer Aldossri; Noha Gomaa; Julie W Farmer; Sonica Singhal; Carlos Quiñonez; Vahid Ravaghi
Journal:  BMC Health Serv Res       Date:  2020-02-17       Impact factor: 2.655

5.  Re-examining the effect of door-to-balloon delay on STEMI outcomes in the context of unmeasured confounders: a retrospective cohort study.

Authors:  Chee Yoong Foo; Nick Andrianopoulos; Angela Brennan; Andrew Ajani; Christopher M Reid; Stephen J Duffy; David J Clark; Daniel D Reidpath; Nathorn Chaiyakunapruk
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

6.  Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia.

Authors:  Rachael Schulte; Ashley Hinson; Van Huynh; Erin H Breese; Joanna Pierro; Seth Rotz; Benjamin A Mixon; Jennifer L McNeer; Michael J Burke; Etan Orgel
Journal:  Cancer Med       Date:  2021-09-16       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.